NCT06401070

Brief Summary

Depression is characterized by behavioral, cognitive and emotional changes. Depression can have a negative impact on decreasing quality of life because in many cases it occurs long-term. Chronic pain is often accompanied by various mental disorders, of which depression is the most common accompanying mental disorder. Chronic pain and depression themselves influence each other and are closely related, with globally around 30% to 45% of patients with chronic pain present with depression, and around 52% to 65% patients with depression suffer from chronic pain. There are various therapeutic options for treating depression that aim to shorten depressive episodes and relieve symptoms. Multimodal therapy is needed in treating depression with chronic pain because there are biopsychosocial aspects involved. Pharmacological therapy has long-term side effects and the risk of drug dependence. Apart from that, depression patients with chronic pain, often receive pharmacological therapy such as non-steroidal anti-inflammatory drugs (NSAIDs) and opioids where the side effects and risk of drug dependence are higher. Therefore, it is necessary to choose a therapeutic modality that is relatively safe and effective in treating depression in chronic pain. In various studies it has been proven that acupuncture is an efficient and safe therapy for chronic pain patients with depression. Auricular acupuncture using pr ess needles has minimal pain and can be applied longer on acupuncture points. This study aimed to assess the effectiveness of the auricular needle press on Patient with Depression Symptoms in Chronic Pain. This study was a double-blinded randomized clinical trial and was carried out on outpatients at Dr. Cipto Mangunkusumo National General Hospital Jakarta and Soerojo Hospital Magelang. There's also a collaborative study between the medical acupuncture department and the psychiatry department. This study includes 60 participants who will be randomly allocated into 2 groups, the press needle and sham press needle groups. The press needles will be placed at 6 auricular points bilaterally : MA-TF1 Shenmen, MA-IC7 Heart, and MA-IT1 Cingulate gyrus. The outcomes that will be assessed in this study are Patient Health Questionnaire-9 (PHQ-9) score and Heart Rate Variability (HRV).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

May 6, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

May 2, 2024

Last Update Submit

May 2, 2024

Conditions

Keywords

acupunctureauricular acupunctureear acupuncturedepression symptomschronic painpress needle

Outcome Measures

Primary Outcomes (2)

  • Patient Health Questionnaire-9 (PHQ-9)

    Consists of nine questions that correspond to the nine questions of the diagnostic criteria for major depressive disorder of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V). In each area assessed, there is a rating from 0 to 3 based on increasing frequency of difficulties. PHQ-9 scoring uses a 4-point Likert scale: 0 = "Not at all," 1 = "Some days," 2 = "More than half the days," and 3 = "Almost every day." With a total score ranging from 0 to 27

    before intervention, the first day, seventh day, and fourteenth-day post intervention

  • Heart Rate Variability (HRV).

    To measure cardiac autonomic dysfunction non-invasively. HRV can be interpreted as the variability of heart rate. Methods for measuring HRV are categorized as time domain, frequency domain, geometric, and nonlinear.

    before intervention, the first day, seventh day, and fourteenth-day post intervention

Study Arms (2)

Control group

PLACEBO COMPARATOR

The control group was given a placebo press needle acupuncture (using plaster)

Device: Plesterin

Intervention Group

EXPERIMENTAL

The intervention group was given press needle acupuncture

Device: Press needle acupuncture

Interventions

PlesterinDEVICE

The plaster used is a round plaster that resembles the shape of an acupuncture press needle.

Control group

Press needle acupuncture is a modality of acupuncture using tiny and very thin needles.

Intervention Group

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Men or women aged 18-59 years.
  • Subjects who experience depression symptoms with chronic pain
  • Subjects with VAS \>= 30 mm and \< 70 mm from 100 mm during activity (daily activities or light exercise).
  • Duration of pain \> 3 months.
  • Patient Health Questionnaire-9 Items (PHQ-9) score 5-19 on a scale of 0-27.
  • Willing to take part in this study until completion and sign the informed consent.

You may not qualify if:

  • Pain caused by malignancy.
  • Patients diagnosed with major depression, depressive symptoms accompanied by psychotic symptoms, and depressive symptoms with antidepressant therapy.
  • patients with medical emergencies or pregnancy.
  • Infection, scar tissue, or malignancy at the acupuncture area.
  • Anatomical abnormalities in the ear shape.
  • Having hypersensitivity reaction to previous acupuncture therapy (metal allergy, atopy, keloid, or other skin hypersensitivity).
  • Patients with cognitive impairment or impaired consciousness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

DepressionChronic Pain

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nur Khasanah

    Medical Faculty Universitas Indonesia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Indonesia University

Study Record Dates

First Submitted

May 2, 2024

First Posted

May 6, 2024

Study Start

May 1, 2024

Primary Completion

September 1, 2024

Study Completion

October 31, 2024

Last Updated

May 6, 2024

Record last verified: 2024-05